Federated Hermes, Inc. Vera Therapeutics, Inc. Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 788,150 shares of VERA stock, worth $16.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
788,150
Previous 1,085,986
27.43%
Holding current value
$16.4 Million
Previous $45.9 Million
58.78%
% of portfolio
0.04%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.7 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$60.9 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $564M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...